BioAllers® New Quick-Dissolving Tablets for Year-Around Allergy Relief : America's #1 Natural Allergy Relief brand has made it even easier for allergy sufferers to find relief.
Bio-Allers® introduces new quick-dissolving allergy medicines.
These 3 new allergy formulas - Indoor Allergy, Outdoor Allergy and Pet Allergy for people - utilize the InstaZol quick-dissolving tablet technology for fast and easy year-around allergy relief. In an extensive research effort, bioAllers® determined that one of the main avenues for reaching new consumers with these natural allergy medicines is a more convenient dosage form that still provides the unique long term advantages of bioAllers® formulas.
According to Mary Beth Watkins, Director of Research and Development for bioAllers®, "absorbtion into the body through the mucous membranes of the mouth is an essential element in the efficacy of the bioAllers® formulations. This allows active ingredients to be directly absorbed into the blood stream, bypassing the digestive system where they can be inactivated by stomach acids and enzymes.
With the new bioAllers® tablets, the body is able to utilize the full benefit of the active ingredients in each dose by gently and gradually exposing the body to specific allergens to help reduce the severity and frequency of allergic episodes." Watkins further added, "research on consumer preference found that tablets are the preferred dosage form for most users".
To meet this consumer demand a new, quick-dissolving tablet was developed to facilitate oral absorption of active ingredients. The results are new, consumer-tested, quick-dissolving tablets for multi-symptom allergy relief with specific allergens. BioAllers® offers a full line of natural, combination homeopathic medicines for treatment of common allergy conditions.
These unique tablet formulas address the symtoms associated with an allergic reaction and provide specific allergens to work with the body to build-up a resistance against future allergic episodes.
Reviews
There are no reviews yet.